#United States #Solon #Biomanufacturing #Locus FS #Bio-Based Additives

Locus Fermentation Solutions Secures Major Investment

Locus Fermentation Solutions (Locus FS), a U.S.-based biotechnology firm, announced a strategic funding success with an oversubscribed investment of $20 million through a convertible note round. This financing, led by Hudson Bay Capital, brings the total funding this year to an impressive $40 million, aimed at expanding its biomanufacturing capabilities and accelerating commercial initiatives.

Transforming Industries with Bio-Based Additives

The focus of this investment is to bolster Locus FS's production of bio-based additives that enhance performance in various industries, including oil & gas, mining, agriculture, and consumer packaged goods (CPG). As the demand for sustainable, effective alternatives to traditional petrochemical-based products increases, Locus FS is uniquely positioned to respond. As John Uhran, CEO of Locus FS, states, “This funding reflects strong confidence in the future of Locus Fermentation Solutions.” The recent growth trajectory, marked by the addition of over 50 new customers in 2025, underscores their success in this rapidly evolving market.

A Commitment to Sustainable Manufacturing

The company stands out as the only U.S. producer of TSCA-approved glycolipid biosurfactants available for commercial-scale operations. These bio-based ingredients are not only non-GMO and palm-free but also exhibit remarkable surface activity and biodegradability while being less toxic compared to traditional alternatives. The funding will enable Locus FS to:

• - Expand its fermentation and downstream processing capabilities in the U.S.
• - Drive commercial success and increase customer acquisition across key markets
• - Accelerate the launch of innovative products
• - Utilize its broad patent portfolio to foster further innovations
• - Implement digital tools to enhance operational performance

Leading the Charge in Sustainable Solutions

Matt Russell from Hudson Bay Capital emphasizes the growing global demand for performance-oriented sustainable formulations, which Locus FS is uniquely positioned to offer. The company’s solutions, particularly their engineered glycolipids and microbials, have already proven effective at scale, making them a viable option for industries looking to enhance their sustainability credentials.

Real-World Impact Across Sectors

Locus FS has established significant commercial traction in its target sectors:

• - Oil & Gas: Glycolipid-enhanced treatments help boost production while ensuring compliance with stringent environmental regulations.
• - Mining: Their biosurfactants improve metal and mineral recovery, enhancing the efficiency of operations like leaching and flotation.
• - Agriculture: Glycolipid-based solutions consistently deliver higher crop yields and improved return on investment for farmers.
• - Industrial and CPG Formulations: These products help formulators reduce the surfactant load, improve performance, and meet clean-label and environmental, social, and governance (ESG) targets.

Conclusion: Looking Ahead

With this fresh influx of funds, Locus FS plans to strengthen its market presence and continue launching innovative products that replace conventional chemistries with high-performance, bio-based alternatives. By leading the charge in sustainable biomanufacturing, Locus FS not only addresses environmental concerns but also delivers effective solutions for critical industries.

For anyone interested in sustainable biotechnology and the future of chemical formulation, Locus Fermentation Solutions is a name to watch.

For additional details and updates, visit Locusfs.com.